Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,175,991 |
|
|||||
| News | - | ||||||
| Day High | 125.50 | Low High |
|||||
| Day Low | 121.68 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 2.40 | 1.97% | 124.29 | 13:17:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 123.15 | 121.68 | 125.50 | 121.89 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 22,099 | 1,175,991 | $ 123.68 | $ 145,448,096 | - | 62.55 - 142.79 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:16:58 | 1 | $ 124.316 | USD |
Moderna (MRNA) Options Flow Summary
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 47.41B | 382.07M | - | 6.85B | -4.71B | -12.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 114.86 | 128.81 | 114.06 | 124.09 | 5,166,315 | 9.43 | 8.21% |
| 1 Month | 107.56 | 128.81 | 99.30 | 113.54 | 3,303,839 | 16.73 | 15.55% |
| 3 Months | 86.13 | 128.81 | 84.80 | 105.29 | 3,882,150 | 38.16 | 44.31% |
| 6 Months | 71.74 | 128.81 | 67.62 | 97.90 | 4,283,905 | 52.55 | 73.25% |
| 1 Year | 131.48 | 142.79 | 62.55 | 102.35 | 4,059,855 | -7.19 | -5.47% |
| 3 Years | 164.00 | 497.17 | 62.55 | 220.16 | 6,853,131 | -39.71 | -24.21% |
| 5 Years | 23.50 | 497.17 | 11.54 | 147.53 | 8,818,927 | 100.79 | 428.89% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
